Article Text

Download PDFPDF
PTU-165 Outcomes of re-implantation of sacral neurostimulation for faecal incon-tinence are similar to those of first time implants
  1. A Cracco1,
  2. S Chadi1,
  3. SD Wexner1,
  4. FG Rodrigues1,
  5. M Zutshi2,
  6. B Gurland2,
  7. G Dasilva1
  1. 1Colorectal Surgery, Cleveland Clinic Florida, Weston
  2. 2Colorectal Surgery, Cleveland Clinic, Cleveland, USA

Abstract

Introduction There is a paucity of data related to the outcome of sacral neurostimulation (SNS) device re-implantation for faecal incontinence (FI). This study aimed to determine the outcomes of re-implantation of SNS for FI.

Method An IRB approved retrospective review of prospectively collected data of patients with FI receiving SNS was performed. Demographic variables, co-morbidities, operative details, reportable events, and functional outcomes were analysed. Continuous variables were assessed for Gaussian distribution. Non-parametric variables were compared with the Mann-Whitney test, and normally distributed variables were compared with an independent samples t-test. In assessing the role of each intervention in decreasing FI score (FIS) comparatively, an analysis of covariance was performed (ANCOVA).

Results 115 patients (mean age 58.5 ± 15 years, 98 females) had implantation of SNS device from 2010–2014. 13% (15/115) underwent lead re-implantation. Implanted and re-implanted groups had similar demographics, co-morbidities, complication, and explantation rates. Operative time was significantly higher in the re-implanted group (first implanted 56.7 ± 17 min; re-implanted 70.1 ± 33 min; p = 0.01). Most common reason for re-implantation was lead-related in 33% (5/15). Loss of efficacy was identified in 20% (3/15) as was lack of efficacy 20% (3/15). Infection was observed in 20% (3/15) of patients, all of whom failed antibiotic therapy and were explanted. A significant decrease in FIS was seen in patients with a first time implantation (median FIS 16 to 7; p < 0.001), and re-implanted patients (median FIS 18 to 12.5; p = 0.036). There was an identifiable difference in preoperative FIS between groups (median FIS implanted 16, re-implanted 18; p = 0.036). ANCOVA analysis did not reveal superiority of either procedure in decreasing FIS (p = 0.284).

Conclusion Reimplantation of SNS is feasible and has similar outcomes as first time implantation. Failure and explantation of SNS should not preclude subsequent reimplantation.

Disclosure of interest None Declared.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.